InsidersTradesSigma
GSS Stock: price and directors' dealings · Australia · ASX
Follow the GSS stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the authority of ASX. Operating in the Health Care sector, GSS has logged 4 insider filings. Market capitalisation: €14.3m. The latest transaction was reported on 2 July 2026 (Initial Substantial Holding). Among the most active insiders: Unknown Substantial Holder. Every trade is accessible without an account.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,670 of 25,973 companies
20.8
score / 100
Value1
Quality41
FCF yld-92%
Earn yld-140%
EV/EBITDA·
ROE-23%
Gross mgn49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations4 total
ShareASXASX:2924-03107151-2A1681941
ShareASXASX:2924-03088041-2A1671113
4 of 4 declarations
About GSS
GSS is a company operating in the health and pharmaceutical sector. It is listed on the XASX market.